Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2007 | 1 |
2014 | 1 |
2016 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review.
Mov Disord. 2023 Mar;38(3):368-377. doi: 10.1002/mds.29278. Epub 2022 Nov 14.
Mov Disord. 2023.
PMID: 36374860
Review.
Spinocerebellar ataxia type 17 or ATX-TBP is a CAG/CAA repeat expansion disorder characterized by marked clinical heterogeneity. ...
Spinocerebellar ataxia type 17 or ATX-TBP is a CAG/CAA repeat expansion disorder characterized by marked clinica …
Differential diagnosis of Huntington's disease: what the clinician should know.
Cardoso F.
Cardoso F.
Neurodegener Dis Manag. 2014;4(1):67-72. doi: 10.2217/nmt.13.78.
Neurodegener Dis Manag. 2014.
PMID: 24640980
Autosomal-dominant diseases that can mimic HD are HD-like 2, C9orf72 mutations, spinocerebellar ataxia type 2, spinocerebellar ataxia type 17 (HD-like 4), benign hereditary chorea, neuroferritinopathy (neurodegeneration with brain …
Autosomal-dominant diseases that can mimic HD are HD-like 2, C9orf72 mutations, spinocerebellar ataxia type 2, spino …
Item in Clipboard
Treatment with a Ginkgo biloba extract, EGb 761, inhibits excitotoxicity in an animal model of spinocerebellar ataxia type 17.
Huang DS, Lin HY, Lee-Chen GJ, Hsieh-Li HM, Wu CH, Lin JY.
Huang DS, et al.
Drug Des Devel Ther. 2016 Feb 18;10:723-31. doi: 10.2147/DDDT.S98156. eCollection 2016.
Drug Des Devel Ther. 2016.
PMID: 26937174
Free PMC article.
Spinocerebellar ataxia type 17 (SCA 17) is a polyglutamine disease caused by the expansion of CAG/CAA repeats in the TATA box-binding protein (TBP) gene. ...Therefore, we suggest that EGb 761 may be a potential therapeutic agent for treat …
Spinocerebellar ataxia type 17 (SCA 17) is a polyglutamine disease caused by the expansion of CAG/CAA rep …
Item in Clipboard
Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes.
Zühlke C, Dalski A, Schwinger E, Finckh U.
Zühlke C, et al.
BMC Med Genet. 2005 Jul 1;6:27. doi: 10.1186/1471-2350-6-27.
BMC Med Genet. 2005.
PMID: 15989694
Free PMC article.
BACKGROUND: Spinocerebellar ataxia type 17 (SCA17), a neurodegenerative disorder in man, is caused by an expanded polymorphic polyglutamine-encoding trinucleotide repeat in the gene for TATA-box binding protein (TBP), a main transcription factor. ...Th …
BACKGROUND: Spinocerebellar ataxia type 17 (SCA17), a neurodegenerative disorder in man, is caused by an expande …
Item in Clipboard
Sporadic case of spinocerebellar ataxia type 17: treatment observations for managing urinary and psychotic symptoms.
Kanai K, Sakakibara R, Uchiyama T, Liu Z, Yamamoto T, Ito T, Hirano S, Asahina M, Kuwabara S, Hattori T, Fukami G, Arai K, Yamaguchi C, Nomura F.
Kanai K, et al.
Mov Disord. 2007 Feb 15;22(3):441-3. doi: 10.1002/mds.21285.
Mov Disord. 2007.
PMID: 17216650
No abstract available.
Item in Clipboard
Cite
Cite